MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Adrian Kemp
Adrian KempASTRAZENECA

Adrian Kemp

Secretary at ASTRAZENECA

Manager

Deal Bio

Total Deals13
Valued Deals13
Total Value£42,658M
Avg. Deal Size£3,281M

Market Context

Expertise (13)

Key Relationships

Sort

Japan
Pharmaceuticals
PrivateAcquisitionJoint Venture
Daiichi Sankyo (trastuzumab Deruxtecan)

target

Daiichi Sankyo (trastuzumab Deruxtecan)

Astrazeneca

bidder

Astrazeneca

£5,258m

11 dealmakers

United States
Biotechnology
MajorityPublicAcquisitionCross Border
Alexion Pharmaceuticals

target

Alexion Pharmaceuticals

Astrazeneca

bidder

Astrazeneca

£29,441m

63 dealmakers

United Kingdom
Pharmaceuticals
AcquisitionCross BorderMajorityPrivate
CRESTOR

target

CRESTOR

GRUNENTHAL

bidder

GRUNENTHAL

£262m

12 dealmakers

United States
Biotechnology
Cross BorderAcquisitionMajorityPrivate
Caelum Biosciences

target

Caelum Biosciences

Astrazeneca

bidder

Astrazeneca

£257m

10 dealmakers

United Kingdom
Pharmaceuticals
Cross BorderMajorityPrivateAcquisition
Astrazeneca (eklira And Duaklir)

target

Astrazeneca (eklira And Duaklir)

Covis Pharma

bidder

Covis Pharma

£197m

13 dealmakers

United States
Biotechnology
MajorityAcquisitionPrivateCross Border
TENEOTWO

target

TENEOTWO

Astrazeneca

bidder

Astrazeneca

£1,048m

14 dealmakers

Netherlands
Biotechnology
Private EquityCross BorderAcquisitionMajorityPrivate
Neogene Therapeutics

target

Neogene Therapeutics

Astrazeneca

bidder

Astrazeneca

£264m

60 dealmakers

United States
Biotechnology
MajorityAcquisitionCross BorderPublicPrivate Equity
Cincor Pharma

target

Cincor Pharma

Astrazeneca

bidder

Astrazeneca

£1,487m

79 dealmakers

France
Biotechnology
MinorityPrivateAcquisitionCross Border
CELLECTIS

target

CELLECTIS

Astrazeneca

bidder

Astrazeneca

£201m

39 dealmakers

United States
Medical Services
AcquisitionCross BorderMajorityTender OfferPublic
Icosavax

target

Icosavax

ASTRAZENECA

bidder

ASTRAZENECA

£876m

27 dealmakers

China
Biotechnology
AcquisitionCross BorderMajorityPublic
Gracell Biotechnologies

target

Gracell Biotechnologies

Astrazeneca

bidder

Astrazeneca

£971m

34 dealmakers

France
Biotechnology
Private EquityAcquisitionPrivateCross BorderMajority
Amolyt Pharma

target

Amolyt Pharma

ASTRAZENECA

bidder

ASTRAZENECA

£820m

60 dealmakers

Canada
Biotechnology
AcquisitionCross BorderMajorityPublic
Fusion Pharmaceuticals

target

Fusion Pharmaceuticals

ASTRAZENECA

bidder

ASTRAZENECA

£1,570m

65 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US